BigHat Biosciences
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
$75MSeries C
ParticipantActivity from announced rounds
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
Provides a secure enterprise AI platform that helps health systems deploy, govern, and scale AI solutions